Attached files
file | filename |
---|---|
8-K - FORM 8-K - NORTHROP GRUMMAN CORP /DE/ | v57777e8vk.htm |
EX-4.A - EX-4.A - NORTHROP GRUMMAN CORP /DE/ | v57777exv4wa.htm |
EX-5.A - EX-5.A - NORTHROP GRUMMAN CORP /DE/ | v57777exv5wa.htm |
Exhibit 1(a)
$1,500,000,000
Northrop Grumman Corporation
$500,000,000 1.850% Senior Notes due 2015
$700,000,000 3.500% Senior Notes due 2021
$300,000,000 5.050% Senior Notes due 2040
$700,000,000 3.500% Senior Notes due 2021
$300,000,000 5.050% Senior Notes due 2040
UNDERWRITING AGREEMENT
November 1, 2010
J.P. Morgan Securities LLC
Citigroup Global Markets Inc.
RBS Securities Inc.
Citigroup Global Markets Inc.
RBS Securities Inc.
As Representatives of the
Several Underwriters
Several Underwriters
c/o J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
383 Madison Avenue
New York, New York 10179
Ladies and Gentlemen:
Northrop Grumman Corporation, a Delaware corporation (the Company), proposes to issue and
sell to the several underwriters (the Underwriters) named in Schedule I hereto for whom you are
acting as representatives (the Representatives) $500,000,000 aggregate principal amount of its
1.850% Senior Notes due 2015 (the Notes due 2015), $700,000,000 aggregate principal amount of its
3.500% Senior Notes due 2021 (the Notes due 2021) and $300,000,000 aggregate principal amount of
its 5.050% Senior Notes due 2040 (the Notes due 2040) (collectively, the Notes). The
respective principal amounts of the Notes to be so purchased by the several Underwriters are set
forth opposite their names in Schedule I hereto. The Notes are to be issued under an indenture,
dated as of November 21, 2001 (the Original Indenture), by and between the Company and The Bank
of New York Mellon, as successor-in-interest to JPMorgan Chase Bank, as trustee (the Trustee), as
supplemented by the first supplemental indenture, dated as of July 30, 2009 (the First
Supplemental Indenture), and the second supplemental indenture to be dated as of November 8, 2010
(the Second Supplemental Indenture); the Original Indenture as supplemented by the First
Supplemental Indenture and the Second Supplemental Indenture, the Indenture), by and between the
Company and the Trustee.
As the Representatives, you have advised the Company (a) that you are authorized to enter into
this Agreement on behalf of the several Underwriters, and (b) that the several Underwriters are
willing, acting severally and not jointly, to purchase the principal amount of Notes set forth
opposite their respective names in Schedule I.
In consideration of the mutual agreements contained herein and of the interests of the parties
in the transactions contemplated hereby, the parties hereto agree as follows:
1. Representations and Warranties of the Company.
The Company represents and warrants to each of the Underwriters as follows:
(a) An automatic shelf registration statement as defined in Rule 405 under the Securities
Act of 1933, as amended (the Act), on Form S-3 (File No. 333-152596) in respect of the Notes,
including a form of prospectus (the Base Prospectus), has been prepared and filed by the Company
not earlier than three years prior to the date hereof, in conformity with the requirements of the
Act and the rules and regulations promulgated by the Securities and Exchange Commission (the
Commission) thereunder (the Rules and Regulations). Such registration statement, which shall
be deemed to include all information omitted therefrom in reliance upon Rules 430A, 430B or 430C
under the Act, is herein referred to as the Registration Statement. The Registration Statement
became effective upon filing under Rule 462(e) under the Act on July 29, 2008. The Company has
not filed a post-effective amendment to the Registration Statement. As used herein, the term
Prospectus means the Base Prospectus together with the prospectus supplement relating to the
Notes first filed with the Commission pursuant to and within the time limits described in Rule
424(b) under the Act and in accordance with Section 4(a). The Base Prospectus, as supplemented by
any preliminary prospectus supplement relating to the Notes filed with the Commission pursuant to
Rule 424(b) under the Act, is herein referred to as a Preliminary Prospectus. Any reference
herein to the Registration Statement, any Preliminary Prospectus or to the Prospectus or to any
amendment or supplement to any of the foregoing documents shall be deemed to refer to and include
the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the Act, as
of the effective date of the Registration Statement or the date of such Preliminary Prospectus or
the Prospectus, as the case may be, and any reference to amend, amendment or supplement with
respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be
deemed to include any documents incorporated by reference therein, and any supplements or
amendments thereto (other than supplements relating only to securities other than the Notes),
filed with the Commission after the date of filing of the Prospectus under Rule 424(b) under the
Act, and prior to the termination of the offering of the Notes by the Underwriters.
(b) As of the Applicable Time (as defined below) and as of the Closing Date (as defined
below), neither (i) the General Use Free Writing Prospectus(es) (as defined below) and the
Statutory Prospectus (as defined below) (collectively, the General Disclosure Package), nor (ii)
any individual Limited Use Free Writing Prospectus (as defined below), when considered together
with the General Disclosure Package, included or will include any untrue statement of a material
fact or omitted or will omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading;
provided, however, that the Company makes no representations or warranties as to
information contained in or omitted from the Statutory Prospectus or any Issuer Free Writing
Prospectus (as defined below), in reliance upon, and in conformity with, written information
furnished to the Company by or on behalf of any Underwriter through any Representative,
specifically for use therein, it being understood and agreed that the only such information is
that described in Section 13. As used in this Agreement:
2
Applicable Time means 5:30 pm (Eastern time) on the date of this Agreement, or such other
time as may be agreed by the Company and the Representatives.
Applicable Date means (i) with respect to a registration statement or any amendment thereto,
the effective date thereof; (ii) with respect to a prospectus, prospectus supplement, pricing
supplement or free-writing prospectus, the date thereof; and (iii) with respect to any filing made
under the Exchange Act, the filing date thereof.
Statutory Prospectus means the Preliminary Prospectus, as amended and supplemented by any
document incorporated by reference therein and any prospectus supplement (including any preliminary
prospectus supplement), in each case immediately prior to the Applicable Time.
Issuer Free Writing Prospectus means any issuer free writing prospectus, as defined in
Rule 433 under the Act, relating to the Notes in the form filed or required to be filed with the
Commission or, if not required to be filed, in the form retained in the Companys records pursuant
to Rule 433(g) under the Act.
General Use Free Writing Prospectus means any Issuer Free Writing Prospectus that is
identified on Schedule II to this Agreement.
Limited Use Free Writing Prospectus means any Issuer Free Writing Prospectus that is not a
General Use Free Writing Prospectus.
(c) The Company has been duly incorporated and is validly existing as a corporation in good
standing under the laws of the State of Delaware, with the corporate power and authority to own or
lease its properties and conduct its business as described in the Registration Statement, the
General Disclosure Package and the Prospectus. The significant subsidiaries (as defined in Rule
1-02(w) of Regulation S-X of the Commission) of the Company are listed in Schedule III to this
Agreement (the Subsidiaries). Each of the Subsidiaries has been duly incorporated or organized
and is validly existing and in good standing under the laws of the respective jurisdiction of its
incorporation or organization, with all corporate power and authority to own or lease its
properties and conduct its business as described in the Registration Statement, the General
Disclosure Package and the Prospectus. The Company and each of the Subsidiaries are duly
qualified as foreign corporations to transact business in all jurisdictions in which the conduct
of their business requires such qualification, except where the failure to be so qualified would
not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect
(as defined below). The outstanding shares of capital stock of each of the Subsidiaries have been
duly authorized and validly issued, are fully paid and non-assessable and are owned by the Company
or another Subsidiary free and clear of all liens, encumbrances and equities and claims; and no
options, warrants or other rights to purchase, agreements or other obligations to issue or other
rights to convert any obligations into shares of capital stock or ownership interests in the
Subsidiaries are outstanding.
(d) The Commission has not issued an order preventing or suspending the use of the
Registration Statement, any Preliminary Prospectus, any Issuer Free Writing Prospectus
3
or the Prospectus relating to the proposed offering of the Notes, and no proceeding for
that purpose or pursuant to Section 8A of the Act has been instituted or, to the Companys
knowledge, threatened by the Commission. The Registration Statement, the Prospectus and any
amendments or supplements thereto at their respective Applicable Dates contained or will contain
all statements which are required to be stated therein by, and conformed or will conform in all
material respects to, the requirements of the Act, the Trust Indenture Act of 1939, as amended
(the Trust Indenture Act), and the Rules and Regulations. The documents incorporated, or to be
incorporated, by reference in the Prospectus, at the time filed with the Commission, conformed, or
will conform, in all material respects to the requirements of the Securities Exchange Act of 1934,
as amended, and the rules and regulations of the Commission thereunder (collectively, the
Exchange Act). The Registration Statement as of its effective date did not contain, and any
post-effective amendment thereto as of its effective date will not contain, any untrue statement
of a material fact and did not omit, and will not omit, to state a material fact required to be
stated therein or necessary in order to make the statements therein not misleading. As of the
date of the Prospectus, as of the date of any amendments and supplements thereto, and as of the
Closing Date, the Prospectus and any such amendments and supplements did not contain, and will not
contain, any untrue statement of a material fact, and did not omit, and will not omit, to state a
material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading; provided, however, that the Company
makes no representations or warranties as to (i) information contained in or omitted from the
Registration Statement or the Prospectus, or any such amendment or supplement, in reliance upon,
and in conformity with, written information furnished to the Company by or on behalf of any
Underwriter through any Representative, specifically for use therein, it being understood and
agreed that the only such information is that described in Section 13, or (ii) that part of the
Registration Statement that constitutes the Statement of Eligibility (Form T-1) of the Trustee
under the Trust Indenture Act.
(e) Each Issuer Free Writing Prospectus, as of its issue date and at all subsequent times
through the completion of the public offer and sale of the Notes, did not, does not and will not
include any information that conflicted, conflicts or will conflict with the information contained
in the Registration Statement, any Preliminary Prospectus not superseded or modified or the
Prospectus, including any document incorporated by reference and any Prospectus Supplement deemed
to be a part thereof that has not been superseded or modified; provided, however,
that the Company makes no representations or warranties as to information contained in or omitted
from any Issuer Free Writing Prospectus in reliance upon, and in conformity with, written
information furnished to the Company by or on behalf of any Underwriter through any
Representative, specifically for use therein, it being understood and agreed that the only such
information is that described in Section 13.
(f) The Company has not, directly or indirectly, distributed and will not distribute any
offering material in connection with the offering and sale of the Notes other than (i) any
Preliminary Prospectus, (ii) the Prospectus, (iii) the General Use Free Writing Prospectus(es),
(iv) each Limited Use Free Writing Prospectus approved in writing in advance by the
Representatives, and (v) other materials, if any, permitted under the Act and consistent with
Section 4(b) and 4(c) below. The Company will file with the Commission all Issuer Free Writing
4
Prospectuses in the time
and manner required under Rules 163(b)(2) and 433(d) under the Act.
(g) (i) At the time of filing of the Registration Statement, (ii) at the time of the most
recent amendment thereto for the purposes of complying with Section 10(a)(3) under the Act
(whether such amendment was by post-effective amendment, incorporated report filed pursuant to
Section 13 or 15(d) of the Exchange Act or form of prospectus), (iii) at the time the Company or
any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under
the Act) made any offer relating to the Notes in reliance on the exemption of Rule 163 under the
Act and (iv) at the date hereof, the Company is a well-known seasoned issuer as defined in Rule
405 under the Act. The Company is eligible to use the Registration Statement as an automatic
shelf registration statement and has not received from the Commission any notice pursuant to Rule
401(g)(2) under the Act objecting to the use of such registration form.
(h) (i) At the earliest time after the filing of the Registration Statement that the Company
or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under
the Act) of the Notes and (ii) as of the date hereof (with such date being used as the
determination date for purposes of this clause (ii)), the Company was not and is not an
ineligible issuer (as defined in Rule 405 under the Act, without taking into account any
determination by the Commission pursuant to Rule 405 under the Act that it is not necessary that
the Company be considered an ineligible issuer), including for purposes of Rules 164 and 433 under
the Act with respect to the offering of the Notes as contemplated by the Registration Statement.
(i) The historical consolidated financial statements of the Company and its consolidated
subsidiaries, together with related notes and schedules thereto, set forth or incorporated by
reference in the Registration Statement, the General Disclosure Package and the Prospectus, comply
as to form in all material respects with the requirements of the Act. Such historical financial
statements fairly present in all material respects the consolidated financial position of the
Company and its consolidated subsidiaries at the respective dates indicated and the results of
their operations and their cash flows for the respective periods indicated, as the case may be, in
conformity with United States generally accepted accounting principles (GAAP) applied on a
consistent basis throughout such periods, except as disclosed therein. The other financial and
statistical information and data included in the Registration Statement, the General Disclosure
Package and the Prospectus are, in all material respects, accurately presented and prepared on a
basis consistent with the financial statements presented therein and the books and records of the
Company.
(j) Deloitte & Touche LLP, who have audited certain of the consolidated financial statements
of the Company and its consolidated subsidiaries filed with the Commission as part of, or
incorporated by reference in, the Registration Statement, the General Disclosure Package and the
Prospectus, as stated in their reports filed with the Commission, are an independent registered
public accounting firm with respect to the Company and its subsidiaries as
5
required by the Act and the applicable Rules and Regulations and by the Public Company
Accounting Oversight Board (United States) (the PCAOB).
(k) Except as set forth in the Registration Statement, the General Disclosure Package and the
Prospectus, no action, suit, claim or proceeding is pending or, to the knowledge of the Company,
threatened against the Company or any of the Subsidiaries before any court or administrative
agency or otherwise which is reasonably likely to either (i) have, individually or in the
aggregate, a material adverse effect on the business, properties, financial position or results of
operations of the Company and its subsidiaries, taken as a whole, or (ii) prevent the consummation
of the transactions contemplated hereby (the occurrence of any such effect or any such prevention
described in the foregoing clauses (i) and (ii) being referred to as a Material Adverse Effect).
(l) The Company and the Subsidiaries have good and marketable title to all real property and
good and marketable title to all personal property owned by them, in each case free and clear of
all liens, encumbrances and defects except such liens, encumbrances and defects as are described
in the Registration Statement, the General Disclosure Package and the Prospectus or such as would
not have a Material Adverse Effect; and any real property and buildings held under lease by the
Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with
such exceptions as would not, individually or in the aggregate, have a Material Adverse Effect.
(m) Except as described in or contemplated by the General Disclosure Package, since the date
of the most recent financial statements of the Company included or incorporated by reference in
the General Disclosure Package, there has not been (i) any Material Adverse Effect, or (ii) any
development reasonably likely to involve a prospective material adverse change in, or materially
and adversely affecting, the business, properties, financial position or results of operations of
the Company and its subsidiaries, taken as a whole, whether or not occurring in the ordinary
course of business, other than changes and transactions described in the Registration Statement,
the General Disclosure Package and the Prospectus.
(n) Neither the Company nor any of the Subsidiaries is or with the giving of notice or lapse
of time or both, will be, (i) in violation of its certificate or articles of incorporation,
by-laws, certificate of formation, limited liability agreement, partnership agreement or other
organizational documents or (ii) in violation of or in default under any agreement, lease,
contract, indenture or other instrument or obligation to which it is a party or by which it, or
any of its properties, is subject, except solely with respect to this clause (ii), for any such
violation or default that would not be reasonably expected to have, individually or in the
aggregate, a Material Adverse Effect. The execution and delivery of this Agreement and the
Indenture and the consummation of the transactions herein and therein contemplated and the
fulfillment of the terms hereof and thereof (including the issuance and sale of the Notes to the
Underwriters) will not conflict with or result in a breach of any of the terms or provisions of,
or constitute a default under, (i) any indenture, mortgage, deed of trust or other agreement or
instrument to which the Company or any Subsidiary is a party or by which the Company or any
Subsidiary or any of its properties, is subject, (ii) the certificate or articles of incorporation
or by-laws of the Company,
6
or (iii) any law, order, rule or regulation judgment, order, writ or decree applicable to the
Company or any Subsidiary of any court or of any government, regulatory body or administrative
agency or other governmental body having jurisdiction; except solely with respect to clauses (i)
and (iii) next above, for any such conflict, breach or default that would not be reasonably
expected to have, individually or in the aggregate, a Material Adverse Effect.
(o) This Agreement has been duly and validly authorized, executed and delivered by the
Company.
(p) The Company has all requisite corporate power and authority to execute, deliver and
perform each of its obligations under the Notes. The Notes, when issued, will be in the form
contemplated by the Indenture. The Notes have been duly and validly authorized by the Company
and, when executed by the Company and authenticated by the Trustee in accordance with the
provisions of the Indenture and when delivered to and paid for by the Underwriters in accordance
with the terms of this Agreement, will constitute valid and legally binding obligations of the
Company, entitled to the benefits of the Indenture, and enforceable against the Company in
accordance with their terms, except that the enforcement thereof may be subject to (i) bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and other similar laws now or
hereafter in effect of general applicability relating to or affecting creditors rights, and (ii)
general principles of equity and the discretion of the court before which any proceeding therefor
may be brought, regardless of whether considered in equity or at law (collectively, the
Enforceability Exceptions).
(q) The Company has all requisite corporate power and authority to perform its obligations
under the Indenture. The Original Indenture has been duly qualified under the Trust Indenture
Act. The Original Indenture and the First Supplemental Indenture have been duly and validly
authorized and duly executed and delivered by the Company and (assuming the due authorization,
execution and delivery by the Trustee), constitute valid and legally binding agreements of the
Company, enforceable against the Company in accordance with its terms, except that the enforcement
thereof may be subject to the Enforceability Exceptions. The Second Supplemental Indenture has
been duly and validly authorized and, when executed and delivered by the Company (assuming the due
authorization, execution and delivery by the Trustee), will constitute a valid and legally binding
agreement of the Company, enforceable against the Company in accordance with its terms, except
that the enforcement thereof may be subject to the Enforceability Exceptions.
(r) Each approval, consent, order, authorization, designation, declaration or filing by or
with any regulatory, administrative or other governmental body necessary in connection with the
execution and delivery by the Company of this Agreement and the consummation of the transactions
herein contemplated (except such additional steps as may be required by the Commission, the
Financial Industry Regulatory Authority, Inc. (FINRA) or such additional steps as may be
necessary to qualify the Notes for public offering by the Underwriters under state securities or
Blue Sky laws) has been obtained or made and is in full force and effect.
7
(s) Neither the Company, nor to the Companys knowledge, any of its affiliates, has taken,
directly or indirectly, any action designed to cause or result in, or which has constituted or
which might reasonably be expected to constitute, the stabilization or manipulation of the price
of any security of the Company to facilitate the sale or resale of the Notes.
(t) Neither the Company nor any Subsidiary is or, after giving effect to the offering and
sale of the Notes contemplated hereunder and the application of the net proceeds from such sale as
described in the Registration Statement, General Disclosure Package and the Prospectus, will be,
an investment company within the meaning of such term under the Investment Company Act of 1940,
as amended (the 1940 Act), and the rules and regulations of the Commission thereunder.
(u) The Company maintains a system of internal control over financial reporting (as defined
in Rule 13a-15(f) of the Exchange Act) that complies with the requirements of the Exchange Act and
has been designed by the Companys principal executive and principal financial officers, or
persons performing similar functions, or under their supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with GAAP. As of December 31, 2009, the Companys internal
control over financial reporting was effective, and the Company is not aware of any material
weaknesses in its internal control over financial reporting.
(v) The Company has established and maintains an effective system of disclosure controls and
procedures (as defined in Rules 13a-14(c) and 15d-14(c) under the Exchange Act) and has carried
out evaluations of the effectiveness of such disclosure controls and procedures as required by
Rule 13a-15 of the Exchange Act.
(w) Neither the Company nor any of the Subsidiaries is in violation of any statute, rule,
regulation, decision or order of any governmental agency or body or any court, domestic or
foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to
the protection or restoration of the environment or human exposure to hazardous or toxic
substances (collectively, environmental laws), owns or operates any real property contaminated
with any substance that is subject to environmental laws, is liable for any off-site disposal or
contamination pursuant to any environmental laws, or is subject to any claim relating to any
environmental laws, which violation, contamination, liability or claim would, individually or in
the aggregate, be reasonably expected to have a Material Adverse Effect.
(x) The Notes and the Indenture will conform in all material respects to the descriptions
thereof in the Prospectus and the General Disclosure Package and will be in substantially the
respective forms filed or incorporated by reference, as the case may be, as exhibits to the
Registration Statement.
2. Purchase, Sale and Delivery of the Notes. On the basis of the representations,
warranties, agreements and covenants herein contained and subject to the terms and conditions
herein set forth, the Company agrees to issue and sell to the Underwriters, and the Underwriters,
acting severally and not jointly, agree to purchase the Notes in the respective principal amounts
8
set forth on Schedule I hereto from the Company at 99.271% of the principal amount of the
Notes due 2015, at 99.018% of the principal amount of the Notes due 2021 and at 99.001% of the
principal amount of the Notes due 2040, in any case together with accrued interest, if any, from
November 8, 2010 to the Closing Date. Such Notes will be represented by one or more definitive
global certificates in book-entry form, in such denomination or denominations as the
Representatives request upon notice to the Company at least 36 hours prior to the Closing Date or,
absent such request, as a single global certificate (collectively, the Global Notes), that will
be deposited by or on behalf of the Company with The Depository Trust Company (DTC) or its
designated custodian. The Company will deliver the Global Notes to the Representatives, for the
account of each Underwriter, against payment by or on behalf of the Underwriters of the purchase
price therefor by wire transfer (immediately available funds), to such account or accounts as the
Company shall specify in writing at least 48 hours prior to the Closing Date, by causing DTC to
credit the Notes to the accounts of the Representatives at DTC (such time and date of delivery
against payment, the Closing Date). The Company will make the Global Notes available for
checking and packaging by the Representatives at the offices of DTC or its designated custodian at
least 24 hours prior to the Closing Date.
3. Offering by the Underwriters.
It is understood that the several Underwriters are to make a public offering of the Notes as
soon as the Representatives deem it advisable to do so. The Notes are to be initially offered to
the public at the initial public offering price set forth in the General Disclosure Package and the
Prospectus. The Representatives may from time to time thereafter change the public offering price
and other selling terms.
4. Covenants of the Company.
The Company covenants and agrees with the several Underwriters that:
(a) The Company will (A) prepare and timely file with the Commission under Rule 424(b)
(without reliance on Rule 424(b)(8)) under the Act a Prospectus in a form approved by the
Representatives containing information previously omitted at the time of effectiveness of the
Registration Statement in reliance on Rule 430A, 430B or 430C under the Act, (B) not, prior to the
expiration of the Prospectus Delivery Period (as defined below), file any amendment to the
Registration Statement, or distribute an amendment or supplement to the General Disclosure Package
or the Prospectus or document incorporated by reference therein (in each case other than (i) an
amendment or supplement consisting solely of the filing of a document required to be filed under
the Exchange Act following the Closing Date or (ii) an amendment to the Registration Statement or
a supplement relating to an offering of securities other than the Notes) of which the
Representatives shall not previously have been advised and furnished with a copy or to which the
Representatives shall have reasonably objected in writing or which is not in compliance in all
material respects with the Rules and Regulations and (C) promptly file all reports and any
definitive proxy or information statements required to be filed by the Company with the Commission
subsequent to the date of the Prospectus and prior to the expiration of the Prospectus Delivery
Period.
9
(b) The Company will (i) not make any offer relating to the Notes that would constitute an
Issuer Free Writing Prospectus or that would otherwise constitute a free writing prospectus (as
defined in Rule 405 under the Act) required to be filed by the Company with the Commission under
Rule 433 under the Act unless the Representatives approve its use in writing prior to first use
(each, a Permitted Free Writing Prospectus); provided that the prior written consent of the
Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing
Prospectus(es) included in Schedule II hereto, (ii) treat each Permitted Free Writing Prospectus
as an Issuer Free Writing Prospectus, (iii) comply with the requirements of Rules 163, 164 and 433
under the Act applicable to any Issuer Free Writing Prospectus, including the requirements
relating to timely filing with the Commission, legending and record keeping and (iv) not take any
action that would result in an Underwriter or the Company being required to file with the
Commission pursuant to Rule 433(d) under the Act a free writing prospectus (as defined in Rule
405 under the Act) prepared by or on behalf of such Underwriter that such Underwriter otherwise
would not have been required to file thereunder.
(c) The Company will prepare a final term sheet (the Final Term Sheet) reflecting the final
terms of the Notes, in form and substance reasonably satisfactory to the Representatives, and
shall file such Final Term Sheet as an Issuer Free Writing Prospectus pursuant to Rule 433 under
the Act prior to the close of business two business days after the date hereof; provided that the
Company shall provide the Representatives with copies of any such Final Term Sheet a reasonable
amount of time prior to such proposed filing and will not use or file any such document to which
the Representatives or counsel to the Underwriters shall reasonably object.
(d) The Company will advise the Representatives promptly (A) when any post-effective
amendment to the Registration Statement, or new registration statement, relating to the Notes
shall have become effective, or any supplement to the Prospectus shall have been filed, (B) of the
receipt of any comments from the Commission relating to the Registration Statement, the Prospectus
or the General Disclosure Package, (C) of any request of the Commission for amendment of the
Registration Statement or the filing of a new registration statement or any amendment or
supplement to the General Disclosure Package or the Prospectus or any document incorporated by
reference therein or otherwise deemed to be a part thereof or for any additional information, in
each case relating to the offering or sale of the Notes, and (D) of the issuance by the Commission
of any stop order suspending the effectiveness of the Registration Statement or such new
registration statement or any order preventing or suspending the use of any Preliminary
Prospectus, any Issuer Free Writing Prospectus or the Prospectus, or of the institution of any
proceedings for that purpose or pursuant to Section 8A of the Act. The Company will use its
reasonable best efforts to prevent the issuance of any such order and to obtain as soon as
possible the lifting thereof, if issued.
(e) If at any time during the Prospectus Delivery Period the Company receives from the
Commission a notice pursuant to Rule 401(g)(2) under the Act or otherwise ceases to be eligible to
use the automatic shelf registration statement form, the Company will (i) promptly notify the
Representatives, (ii) promptly file a new registration statement or post-effective amendment on
the proper form relating to the Notes, in a form satisfactory to the
10
Representatives, (iii) use its reasonable best efforts to cause such registration statement or
post-effective amendment to be declared effective as soon as practicable (if such filing is not
otherwise effective immediately pursuant to Rule 462 under the Act), and (iv) promptly notify the
Representatives of such effectiveness. The Company will take all other action necessary to permit
the public offering and sale of the Notes to continue as contemplated in the Registration
Statement that was the subject of the notice under Rule 401(g)(2) under the Act or for which the
Company has otherwise become ineligible. References herein to the Registration Statement relating
to the Notes shall include such new registration statement or post-effective amendment, as the
case may be.
(f) The Company agrees to pay the required filing fees to the Commission relating to the
Notes within the time required by Rule 456(b)(1) under the Act without regard to the proviso
therein and otherwise in accordance with Rules 456(b) and 457(r) under the Act.
(g) The Company will cooperate with the Representatives in endeavoring to qualify the Notes
for sale under the securities laws of such jurisdictions in the United States as the
Representatives may reasonably have designated in writing and will make such applications, file
such documents, and furnish such information as may be reasonably required for that purpose;
provided the Company shall not be required to qualify as a foreign corporation or to file a
general consent to service of process in any jurisdiction where it is not now so qualified or
required to file such a consent. The Company will, from time to time, prepare and file such
statements, reports, and other documents, as are or may be required to continue such
qualifications in effect for so long a period as the Representatives may reasonably request for
distribution of the Notes.
(h) The Company will deliver to the Representatives as many copies of any Preliminary
Prospectus or any Issuer Free Writing Prospectus as the Representatives may reasonably request.
The Company will deliver to the Representatives during the period when delivery of a Prospectus
(or, in lieu thereof, the notice referred to under Rule 173(a) under the Act) is required by law
to be delivered by an Underwriter or dealer (the Prospectus Delivery Period), as many copies of
the Prospectus in final form, or as thereafter amended or supplemented, as the Representatives may
reasonably request. The Company will deliver to the Representatives at or before the Closing
Date, four photocopies of an executed copy of the Registration Statement and all amendments
thereto including all exhibits filed therewith, and will deliver to the Representatives such
number of conformed copies of the Registration Statement (including such number of copies of the
exhibits filed therewith that may reasonably be requested) and of all amendments thereto, as the
Representatives may reasonably request.
(i) The Company will comply with the Act, the Rules and Regulations, the Exchange Act and the
Trust Indenture Act, and the rules and regulations of the Commission thereunder, so as to permit
the completion of the distribution of the Notes as contemplated in this Agreement and the
Prospectus. If during the Prospectus Delivery Period any event shall occur as a result of which,
in the judgment of the Company or in the reasonable opinion of the Underwriters, the Prospectus
includes any untrue statement of a material fact or omits to state a material fact necessary in
order to make the statements therein, in the light of the circumstances
11
existing at the time the Prospectus is delivered to a purchaser, not misleading, or, if it is
necessary at any time to amend or supplement the Prospectus to comply in all material respects
with the Act or the Rules and Regulations, the Company promptly will either (i) prepare and file
with the Commission an appropriate amendment to the Registration Statement or amendment or
supplement to the Prospectus or (ii) prepare and file with the Commission an appropriate filing
under the Exchange Act which shall be incorporated by reference in the Prospectus; so that in
either case the Prospectus as so amended or supplemented (1) does not include any untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances existing when it is so delivered, not misleading, or
(2) so complies with such law.
(j) If the General Disclosure Package is being used to solicit offers to buy the Notes at a
time when the Prospectus is not yet available to prospective purchasers and any event shall occur
as a result of which, in the judgment of the Company or in the reasonable opinion of the
Underwriters, the General Disclosure Package at the time the General Disclosure Package is being
used includes any untrue statement of a material fact or omits to state a material fact necessary
in order to make the statements therein, in the light of the circumstances existing, not
misleading, the statements therein conflict with the information contained in the Registration
Statement then on file in any material respect, or, if it is necessary at any time to amend or
supplement the General Disclosure Package to comply in any material respect with the Act or the
Rules and Regulations, the Company promptly will either (i) prepare, file with the Commission (if
required) and furnish to the Underwriters and any dealers an appropriate amendment or supplement
to the General Disclosure Package or (ii) prepare and file with the Commission an appropriate
filing under the Exchange Act which shall be incorporated by reference in the General Disclosure
Package; so that in either case the General Disclosure Package as so amended or supplemented at
such time (1) does not include any untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances
existing, not misleading, (2) does not so conflict with the Registration Statement then on file,
or (3) so complies with such law.
(k) The Company will make generally available to its security holders, as soon as it is
practicable to do so, but in any event not later than 15 months after the effective date of the
Registration Statement (as defined in Rule 158(c) under the Act), an earnings statement or
statements (which need not be audited) complying with the requirements of Section 11(a) of the Act
and Rule 158 under the Act.
(l) During the period beginning on the date hereof and continuing to the date that is 7 days
after the Closing Date, without the prior written consent of the Representatives, the Company will
not offer, sell, contract to sell or otherwise dispose of, except as provided hereunder, any
securities of the Company (or guaranteed by the Company) that are substantially similar to the
Notes.
(m) The Company shall apply the net proceeds of its sale of the Notes as set forth in the
Registration Statement, the General Disclosure Package and the Prospectus.
12
(n) The Company shall not invest, or otherwise use, the proceeds received by the Company from
its sale of the Notes in such a manner as would require the Company or any of the Subsidiaries to
register as an investment company under the 1940 Act.
(o) The Company will not take, directly or indirectly, any action designed to cause or result
in, or that has constituted or might reasonably be expected to constitute, the stabilization or
manipulation of the price of the Notes.
5. Covenants of the Underwriters.
(a) Each Underwriter hereby agrees that it has not and will not use, authorize use of, refer
to, or participate in the planning for use of, any free writing prospectus (as defined in Rule
405 under the Act) (which term includes use of any written information furnished to the Commission
by the Company and not incorporated by reference into the Registration Statement and any press
release issued by the Company) other than (i) a free writing prospectus that, solely as a result
of use by such Underwriter, would not trigger an obligation to file such free writing prospectus
with the Commission or is not required to be retained by the Company pursuant to Rule 163 or Rule
433, (ii) any Issuer Free Writing Prospectus listed on Schedule II or prepared pursuant to Section
4(b) or Section 4(c) above, or (iii) any free writing prospectus prepared by such Underwriter and
approved by the Company in advance in writing.
(b) Each Underwriter hereby (i) agrees that it will not knowingly offer, sell or deliver any
of the Notes in any jurisdiction outside the United States except under circumstances that will
result in compliance with the applicable laws thereof, and that it will take at its own expense
whatever action is required to permit its resale of the Notes in such jurisdictions, and (ii)
acknowledges that no action has been taken by such Underwriter to permit a public offering in any
jurisdiction outside the United States where action would be required for such purpose.
6. Costs and Expenses.
(a) The Company will pay all costs, expenses and fees incident to the performance of the
obligations of the Company under this Agreement, including, without limiting the generality of the
foregoing, the following: accounting fees of the Company; the fees and disbursements of counsel
for the Company; any roadshow expenses; the cost of printing and delivering to, or as reasonably
requested by, the Underwriters copies of the Registration Statement, Preliminary Prospectuses,
Statutory Prospectus, the Issuer Free Writing Prospectuses, the Prospectus, this Agreement, the
Indenture; the filing fees of the Commission; the filing fees and expenses (including reasonable
legal fees and disbursements) incident to securing any required review by FINRA of the terms of
the sale of the Notes; any fees payable to rating agencies in connection with the rating of the
Notes; the reasonable expenses, including the reasonable fees and disbursements of counsel for the
Underwriters, incurred in connection with the qualification of the Notes under State securities or
Blue Sky laws and the preparation, printing and distribution of a Blue Sky memorandum and any
supplements or amendments thereto; and
13
the fees and expenses of the Trustee, including reasonable fees and expenses of counsel for
the Trustee.
(b) The Company shall not be required to pay for any of the Underwriters expenses (other
than those related to qualification under FINRA regulations and state securities or Blue Sky
laws) except that, if this Agreement shall not be consummated because this Agreement is terminated
by the Representatives pursuant to Section 7, unless the failure to satisfy the applicable
conditions thereof is due primarily to the default or omission of any Underwriter, the Company
shall reimburse the several Underwriters for reasonable out-of-pocket expenses, including
reasonable fees and disbursements of counsel, reasonably incurred in connection with
investigating, marketing and proposing to market the Notes.
7. Conditions of Obligations of the Underwriters.
The several obligations of the Underwriters to purchase the Notes on the Closing Date are
subject to the accuracy, as of the Applicable Time or the Closing Date, as the case may be, of the
representations and warranties of the Company contained herein, and to the performance by the
Company of its covenants and obligations hereunder and to the following additional conditions:
(a) The Registration Statement and all post-effective amendments thereto shall have become
effective and the Prospectus and each Issuer Free Writing Prospectus required shall have been
filed as required by Rules 424(b) (without reliance on Rule 424(b)(8)), 430A, 430B, 430C or 433
under the Act, as applicable, within the time period prescribed by, and in compliance with, the
Rules and Regulations, and any request of the Commission for additional information (to be
included in the Registration Statement or otherwise) shall have been disclosed to the
Representatives and complied with to their reasonable satisfaction. No stop order suspending the
effectiveness of the Registration Statement, as amended from time to time, shall have been issued
and no proceedings for that purpose or pursuant to Section 8A under the Act shall have been taken
or, to the knowledge of the Company, shall be contemplated or threatened by the Commission and no
injunction, restraining order or order of any nature by a federal or state court of competent
jurisdiction shall have been issued as of the Closing Date which would prevent the issuance of the
Notes.
(b) The Representatives shall have received on the Closing Date the opinions of Sheppard,
Mullin, Richter & Hampton LLP, counsel for the Company, dated the Closing Date,
addressed to the Underwriters, substantially to the effect set forth in Exhibit A hereto.
(c) The Representatives shall have received from Sullivan & Cromwell LLP, counsel for the
Underwriters, an opinion dated the Closing Date covering such matters as the Representatives may
reasonably request.
(d) The Representatives shall have received, on each of the date hereof and the Closing Date,
a letter dated the date hereof and the Closing Date, in form and substance satisfactory to the
Representatives and addressed to the Underwriters, of Deloitte & Touche LLP
14
confirming that they are an independent registered public accounting firm with respect to the
Company and its subsidiaries within the meaning of the Act and the applicable Rules and
Regulations and the PCAOB and stating that in their opinion the financial statements and schedules
examined by them and included or incorporated by reference in the Registration Statement, the
General Disclosure Package and the Prospectus comply in form in all material respects with the
applicable accounting requirements of the Act and the related Rules and Regulations; and
containing such other statements and information as is ordinarily included in accountants
comfort letters to Underwriters with respect to the financial statements and certain financial
information contained in the Registration Statement, the General Disclosure Package and the
Prospectus.
(e) The Representatives shall have received on the Closing Date a certificate or certificates
of the Treasurer and the Assistant Treasurer of the Company, in their capacities as officers of
the Company, to the effect that, as of the Closing Date, each of them severally certifies to the
best of his or her knowledge as follows:
(i) The Registration Statement has become effective under the Act and no stop order suspending
the effectiveness of the Registration Statement or no order preventing or suspending the use of any
Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus has been issued, and
no proceedings for such purpose or pursuant to Section 8A of the Act have been taken or are, to his
or her knowledge, contemplated or threatened by the Commission;
(ii) The representations and warranties of the Company contained in Section 1 are true and
correct as of the Closing Date;
(iii) All filings required to have been made pursuant to Rules 424(b), 430A, 430B or 430C
under the Act have been made as and when required by such rules;
(iv) Since the respective dates as of which information is given in the Registration
Statement, the General Disclosure Package and Prospectus, there has not been any material adverse
change, or any development reasonably likely to involve a prospective material adverse change, in
or affecting the business, properties, financial position or results of operations of the Company
and its subsidiaries, taken as a whole, whether or not arising in the ordinary course of business.
(f) The Representatives shall have been furnished with such further certificates and
documents confirming the representations and warranties, covenants and conditions contained herein
and related matters as the Representatives may reasonably have requested.
(g) Subsequent to the earlier of (A) the Applicable Time and (B) the execution and delivery
of this Agreement, (i) no downgrading shall have occurred in the rating of the Notes or any other
debt securities or preferred stock of or guaranteed by the Company or any Subsidiary by any
nationally recognized statistical rating organization, as such term is defined by the Commission
for purposes of Rule 436(g)(2) under the Act and (ii) no such organization
15
shall have publicly announced that it has under surveillance or review, or has changed
its outlook with respect to, its rating of the Notes or of any other debt securities or preferred
stock of or guaranteed by the Company or any Subsidiary (other than an announcement with positive
implications of a possible upgrading).
(h) Subsequent to the earliest of (A) the Applicable Time, (B) the execution and delivery of
this Agreement and (C) the respective dates as of which information is given in the Registration
Statement, the General Disclosure Package and Prospectus, there has not been (i) any material
adverse change, or any development reasonably likely to involve a prospective material adverse
change, in or affecting the business, properties, financial position or results of operations of
the Company and its subsidiaries, taken as a whole, whether or not arising in the ordinary course
of business, the effect of which would, in your judgment, make it impracticable or inadvisable to
market the Notes or to enforce contracts for the sale of the Notes, or (ii) any suspension of
trading of the Companys common stock by the New York Stock Exchange, the Commission, or any other
governmental authority.
The opinions and certificates mentioned in this Agreement shall be deemed to be in compliance
with the provisions hereof only if they are in all material respects reasonably satisfactory to the
Representatives and to Sullivan & Cromwell LLP, counsel for the Underwriters.
If any of the conditions hereinabove provided for in this Section 7 shall not have been
fulfilled when and as required by this Agreement to be fulfilled, the obligations of the
Underwriters hereunder may be terminated by the Representatives by notifying the Company of such
termination in writing or by telegram at or prior to the Closing Date.
8. Indemnification.
(a) The Company agrees:
(1) to indemnify and hold harmless each Underwriter, the directors and officers of each
Underwriter and each person, if any, who controls any Underwriter within the meaning of
either Section 15 of the Act or Section 20 of the Exchange Act, against any losses, claims,
damages or liabilities to which such Underwriter or any such controlling person may become
subject under the Act or otherwise, insofar as such losses, claims, damages or liabilities
(or actions or proceedings in respect thereof) arise out of or are based upon (i) any untrue
statement or alleged untrue statement of any material fact contained in the Registration
Statement, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus or
any amendment or supplement thereto, (ii) with respect to the Registration Statement or any
amendment or supplement thereto, the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not
misleading or (iii) with respect to any Preliminary Prospectus, any Issuer Free Writing
Prospectus, the Prospectus or any amendment or supplement thereto, the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make
the statements therein not misleading in the light of the circumstances under which they
were made; provided, however, that the Company
16
will not be liable in any such case to the extent that any such loss,
claim, damage or liability arises out of or is based upon an untrue statement or alleged
untrue statement, or omission or alleged omission made in the Registration Statement, any
Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus, or such
amendment or supplement, in reliance upon and in conformity with written information
furnished to the Company through any Representative, specifically for use therein, it being
understood and agreed that the only such information furnished by any Underwriter consists
of the information described as such in Section 13; and
(2) to reimburse each Underwriter, each Underwriters directors and officers, and each
such controlling person upon demand for any legal or other out-of-pocket expenses reasonably
incurred by such Underwriter or such controlling person in connection with investigating or
defending any such loss, claim, damage or liability, action or proceeding or in responding
to a subpoena or governmental inquiry related to the offering of the Notes, whether or not
such Underwriter or controlling person is a party to any action or proceeding. In the event
that it is finally judicially determined that the Underwriters or such controlling person,
director or officer were not entitled to receive payments for legal and other expenses
pursuant to this subparagraph, the Underwriters, on behalf of themselves or on behalf of
such controlling person, director or officer, as the case may be, will promptly return all
sums that had been advanced pursuant hereto.
(b) Each Underwriter severally and not jointly will indemnify and hold harmless the Company,
each of its directors, each of its officers who have signed the Registration Statement and each
person, if any, who controls the Company within the meaning of the Act, against any losses,
claims, damages or liabilities to which the Company or any such director, officer or controlling
person may become subject under the Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) arise out of or are based upon (i) any
untrue statement or alleged untrue statement of any material fact contained in the Registration
Statement, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus or any
amendment or supplement thereto, (ii) with respect to the Registration Statement or any amendment
or supplement thereto, the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading or (iii) with
respect to any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus or any
amendment or supplement thereto, the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein not misleading in the
light of the circumstances under which they were made; and will reimburse any legal or other
expenses reasonably incurred by the Company or any such director, officer or controlling person in
connection with investigating or defending any such loss, claim, damage, liability, action or
proceeding; provided, however, that each Underwriter will be liable in each case
to the extent, but only to the extent, that such untrue statement or alleged untrue statement or
omission or alleged omission has been made in the Registration Statement, any Preliminary
Prospectus, any Issuer Free Writing Prospectus, the Prospectus or such amendment or supplement, in
reliance upon and in conformity with written information furnished to the Company through any
Representative, specifically for use therein, it being understood and agreed that the only such
information furnished by any Underwriter
17
consists of the information described as such in Section 13. This indemnity agreement will
be in addition to any liability which such Underwriter may otherwise have.
(c) In case any proceeding (including any governmental investigation) shall be instituted
involving any person in respect of which indemnity may be sought pursuant to this Section 8, such
person (the indemnified party) shall promptly notify the person against whom such indemnity may
be sought (the indemnifying party) in writing. No indemnification provided for in Section 8(a)
or (b) shall be available to any party who shall fail to give notice as provided in this Section
8(c) if the party to whom notice was not given was unaware of the proceeding to which such notice
would have related and was materially prejudiced by the failure to give such notice, but the
failure to give such notice shall not relieve the indemnifying party or parties from any liability
which it or they may have to the indemnified party for contribution or otherwise than on account
of the provisions of Section 8(a) or (b). In case any such proceeding shall be brought against
any indemnified party and it shall notify the indemnifying party of the commencement thereof, the
indemnifying party shall be entitled to participate therein and, to the extent that it shall wish,
jointly with any other indemnifying party similarly notified, to assume the defense thereof, with
counsel reasonably satisfactory to such indemnified party and shall pay as incurred the reasonable
fees and disbursements of such counsel related to such proceeding. In any such proceeding, any
indemnified party shall have the right to retain its own counsel at its own expense.
Notwithstanding the foregoing, the indemnifying party shall pay as incurred (or within 30 days of
presentation) the reasonable fees and expenses of the counsel retained by the indemnified party in
the event (i) the indemnifying party and the indemnified party shall have mutually agreed to the
retention of such counsel, (ii) the named parties to any such proceeding (including any impleaded
parties) include both the indemnifying party and the indemnified party and, in the opinion of
outside counsel, representation of both parties by the same counsel would be inappropriate due to
actual or potential differing interests between them or (iii) the indemnifying party shall have
failed to assume the defense and employ counsel acceptable to the indemnified party within a
reasonable period of time after notice of commencement of the action. Such firm shall be
designated in writing by you in the case of parties indemnified pursuant to Section 8(a) and by
the Company in the case of parties indemnified pursuant to Section 8(b). The indemnifying party
shall not be liable for any settlement of any proceeding effected without its written consent but
if settled with such consent or if there be a final judgment for the plaintiff not subject to
further appeal, the indemnifying party agrees to indemnify the indemnified party from and against
any loss or liability by reason of such settlement or judgment. In addition, the indemnifying
party will not, without the prior written consent of the indemnified party, settle or compromise
or consent to the entry of any judgment in any pending or threatened claim, action or proceeding
of which indemnification may be sought hereunder (whether or not any indemnified party is an
actual or potential party to such claim, action or proceeding) unless such settlement, compromise
or consent includes an unconditional release of each indemnified party from all liability arising
out of such claim, action or proceeding.
(d) To the extent the indemnification provided for in this Section 8 is unavailable to or
insufficient to hold harmless an indemnified party under Section 8(a) or (b) above in respect of
any losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred
to therein, then each indemnifying party shall contribute to the amount
18
paid or payable by such indemnified party as a result of such losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) in such proportion as is appropriate to
reflect the relative benefits received by the Company on the one hand and the Underwriters on the
other from the offering of the Notes. If, however, the allocation provided by the immediately
preceding sentence is not permitted by applicable law then each indemnifying party shall
contribute to such amount paid or payable by such indemnified party in such proportion as is
appropriate to reflect not only such relative benefits but also the relative fault of the Company
on the one hand and the Underwriters on the other in connection with the statements or omissions
which resulted in such losses, claims, damages or liabilities (or actions or proceedings in
respect thereof), as well as any other relevant equitable considerations. The relative benefits
received by the Company on the one hand and the Underwriters on the other shall be deemed to be in
the same proportion as the total net proceeds from the offering (before deducting expenses)
received by the Company bear to the total underwriting discounts and commissions received by the
Underwriters, in each case as set forth in the table on the cover page of the Prospectus. The
relative fault shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the Company on the one hand or the Underwriters
on the other and the parties relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission.
The Company and the Underwriters agree that it would not be just and equitable if
contributions pursuant to this Section 8(d) were determined by pro rata allocation (even if the
Underwriters were treated as one entity for such purpose) or by any other method of allocation
which does not take account of the equitable considerations referred to above in this Section 8(d).
The amount paid or payable by an indemnified party as a result of the losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) referred to above in this Section 8(d)
shall be deemed to include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim. Notwithstanding the
provisions of this Section 8(d), (i) no Underwriter shall be required to contribute any amount in
excess of the underwriting discounts and commissions applicable to the Notes purchased by such
Underwriter, and (ii) no person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of
such fraudulent misrepresentation. The Underwriters obligations in this Section 8(d) to
contribute are several in proportion to their respective underwriting obligations and not joint.
(e) In any proceeding relating to the Registration Statement, any Preliminary Prospectus, any
Issuer Free Writing Prospectus, the Prospectus or any supplement or amendment thereto, each party
against whom contribution may be sought under this Section 8 hereby consents to the jurisdiction
of any court having jurisdiction over any other contributing party, agrees that process issuing
from such court may be served upon it by any other contributing party and consents to the service
of such process and agrees that any other contributing party may join it as an additional
defendant in any such proceeding in which such other contributing party is a party.
19
(f) Any losses, claims, damages, liabilities or expenses for which an indemnified party is
entitled to indemnification or contribution under this Section 8 shall be paid by the indemnifying
party to the indemnified party as such losses, claims, damages, liabilities or expenses are
incurred. The indemnity and contribution agreements contained in this Section 8 and the
representations and warranties of the Company set forth in this Agreement shall remain operative
and in full force and effect, regardless of (i) any investigation made by or on behalf of any
Underwriter, its directors or officers or any person controlling any Underwriter, the Company, its
directors or officers or any persons controlling the Company, (ii) acceptance of any Notes and
payment therefor hereunder, and (iii) any termination of this Agreement. A successor to any
Underwriter, its directors or officers or any person controlling any Underwriter, or to the
Company, its directors or officers, or any person controlling the Company, shall be entitled to
the benefits of the indemnity, contribution and reimbursement agreements contained in this Section
8.
9. Default by Underwriters.
If on the Closing Date any Underwriter shall fail to purchase and pay for the principal amount
of the Notes which such Underwriter has agreed to purchase and pay for on such date (otherwise than
by reason of any default on the part of the Company), you, as Representatives of the Underwriters,
shall use your reasonable efforts to procure within 36 hours thereafter one or more of the other
Underwriters, or any others, to purchase from the Company such principal amounts as may be agreed
upon, and upon the terms set forth herein, the Notes which the defaulting Underwriter or
Underwriters failed to purchase. If during such 36 hours you, as such Representatives, shall not
have procured such other Underwriters, or any others, to purchase the principal amount of the Notes
agreed to be purchased by the defaulting Underwriter or Underwriters, then the Company shall be
entitled to a further period of 36 hours within which to procure another party or parties
satisfactory to you to purchase from the Company such principal amount of the Notes on such terms.
If, after giving effect to any arrangements for the purchase of Notes by a defaulting Underwriter
by your or the Company, as provided above in this Section 9, (a) the aggregate principal amount of
Notes with respect to which such default shall occur does not exceed 10% of the aggregate principal
amount of the Notes to be purchased on the Closing Date, the other Underwriters shall be obligated,
severally, in proportion to the respective principal amounts of the Notes which they are obligated
to purchase hereunder, to purchase the Notes which such defaulting Underwriter or Underwriters
failed to purchase, or (b) the aggregate principal amount of the Notes with respect to which such
default shall occur exceeds 10% of the aggregate principal amount of the Notes to be purchased on
the Closing Date, the Company or you as the Representatives of the Underwriters will have the
right, by written notice given within the next 36-hour period to the parties to this Agreement, to
terminate this Agreement without liability on the part of the non-defaulting Underwriters or of the
Company, except to the extent provided in Sections 5 and 8. In the event of a default by any
Underwriter or Underwriters, as set forth in this Section 9, the Closing Date may be postponed for
such period, not exceeding seven days, as you, as Representatives, or the Company may determine in
order that the required changes in the Registration Statement, the General Disclosure Package or in
the Prospectus or in any other documents or arrangements may be effected. The term Underwriter
includes any person substituted for a defaulting Underwriter. Any action taken under this Section
9 shall not
20
relieve any defaulting Underwriter from liability in respect of any default of such
Underwriter under this Agreement.
10. Notices.
All communications hereunder shall be in writing and, except as otherwise provided herein,
will be mailed, delivered, telecopied or telegraphed and confirmed as follows: if to the
Underwriters, to (i) J.P. Morgan Securities LLC, 383 Madison Avenue, 3rd Floor, New
York, New York 10179; (ii) Citigroup Global Markets Inc., 388 Greenwich Street, New York, New York
10013, Attention: General Counsel; (iii) RBS Securities Inc., 600 Washington Blvd., Stamford,
Connecticut 06901, Attention: Debt Capital Markets Syndicate; or (iv) if to the Company, to the
address set forth in the Registration Statement, Attention: Deputy General Counsel, with a copy
(which copy shall not constitute notice) to Sheppard, Mullin, Richter & Hampton LLP, 333 South Hope
Street, Forty-Third Floor, Los Angeles, CA 90071, Attention: John D. Tishler and Louis Lehot.
11. Termination.
This Agreement may be terminated by you by notice to the Company (a) at any time prior to the
Closing Date if any of the following has occurred: (i) any outbreak or escalation of hostilities
or declaration of war or national emergency or other national or international calamity or crisis
after the Applicable Time, if the effect of such outbreak, escalation, declaration, emergency,
calamity or crisis on the financial markets of the United States would, in your judgment, make it
impracticable or inadvisable to market the Notes or to enforce contracts for the sale of the Notes,
(ii) any material change in economic or political conditions after the Applicable Time, if the
effect of such change on the financial markets of the United States would, in your judgment, make
it impracticable or inadvisable to market the Notes or to enforce contracts for the sale of the
Notes, (iii) suspension of trading in securities generally on the New York Stock Exchange, the
American Stock Exchange or the Nasdaq Global Select Market or limitation on prices (other than
limitations on hours or numbers of days of trading) for securities on any such Exchange after the
Applicable Time, or (iv) the declaration of a banking moratorium by United States or New York State
authorities after the Applicable Time; or (b) as provided in Sections 7 and 9. In such event, the
Company, on the one hand, and the Representatives and Underwriters, on the other hand, shall have
no liability or any further obligations to the other except to the extent provided in Sections 6, 8
and 9.
12. Successors.
This Agreement has been and is made solely for the benefit of the Underwriters and the Company
and their respective successors, executors, administrators, heirs and assigns, and the officers,
directors and controlling persons referred to herein, and no other person will have any right or
obligation hereunder. No purchaser of any of the Notes from any Underwriter shall be deemed a
successor or assign merely because of such purchase.
21
13. Information Provided by Underwriters.
The Company and the Underwriters acknowledge and agree that the only information furnished or
to be furnished by any Underwriter to the Company for inclusion in the Registration Statement, any
Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus consists of (i) the
names of the Underwriters set forth on the front and back covers of the Preliminary Prospectus, the
Prospectus and in any Issuer Free Writing Prospectus and (ii) the information set forth in the
first, third, sixth and eighth through twelfth paragraphs under the caption Underwriting in the
Prospectus.
14. No Advisory or Fiduciary Responsibility.
The Company acknowledges and agrees that (i) the purchase and sale of the Notes pursuant to
this Agreement is an arms-length commercial transaction between the Company, on the one hand, and
the Underwriters, on the other, (ii) in connection therewith and with the process leading to such
transaction each Underwriter is acting solely as a principal and not the agent or fiduciary of the
Company, (iii) no Underwriter has assumed an advisory or fiduciary responsibility in favor of the
Company with respect to the offering contemplated hereby or the process leading thereto
(irrespective of whether such Underwriter has advised or is currently advising the Company on other
matters) or any other obligation to the Company except the obligations expressly set forth in this
Agreement and (iv) the Company has consulted its own legal and financial advisors to the extent it
deemed appropriate. The Company agrees that it will not claim that any Underwriter has rendered
advisory services of any nature or respect, or owes a fiduciary or similar duty to the Company, in
connection with such transaction or the process leading thereto.
15. Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument.
16. Survival Clause.
The reimbursement, indemnification and contribution agreements contained in this Agreement and
the representations, warranties and covenants in this Agreement shall remain in full force and
effect regardless of (a) any termination of this Agreement, (b) any investigation made by or on
behalf of any Underwriter or controlling person thereof, or by or on behalf of the Company or its
directors or officers and (c) delivery of and payment for the Notes under this Agreement.
17. Governing Law.
This Agreement shall be governed by, and construed in accordance with, the law of the State of
New York, including Section 5-1401 of the New York General Obligations Law.
22
If the foregoing letter is in accordance with your understanding of our agreement, please sign
and return to us the enclosed duplicates hereof, whereupon it will become a binding agreement among
the Company and the several Underwriters in accordance with its terms.
Very truly yours, | ||||
NORTHROP GRUMMAN CORPORATION |
||||
By | /s/ Mark Rabinowitz | |||
Name: | Mark Rabinowitz | |||
Title: | Corporate Vice President & Treasurer | |||
The foregoing Underwriting Agreement
is hereby confirmed and accepted as of
the date first above written.
|
||
J.P. MORGAN SECURITIES LLC
CITIGROUP GLOBAL MARKETS INC.
RBS SECURITIES INC. |
||
As Representatives of the several
Underwriters listed on Schedule I |
||
By: J.P. Morgan Securities LLC |
By | /s/ Robert Bottamedi | |||
Name: | Robert Bottamedi | |||
Title: | Vice President |
By: Citigroup Global Markets Inc.
By | /s/ Jack D. McSpadden, Jr. | |||
Name: | Jack D. McSpadden, Jr. | |||
Title: | Managing Director |
By: RBS Securities Inc.
By | /s/ Michael L. Saron | |||
Name: | Michael L. Saron | |||
Title: | Managing Director |
SCHEDULE I
SCHEDULE OF UNDERWRITERS
Aggregate Principal | Aggregate Principal | |||||||||||
Amount of | Amount of 3.500% | Aggregate Principal | ||||||||||
1.850% Senior Notes | Senior Notes due | Amount of 5.050% | ||||||||||
due 2015 | 2021 | Senior Notes due 2040 | ||||||||||
Underwriter | to be Purchased | to be Purchased | to be Purchased | |||||||||
Citigroup Global Markets Inc. |
$ | 75,000,000 | $ | 105,000,000 | $ | 45,000,000 | ||||||
J.P. Morgan Securities LLC |
$ | 75,000,000 | $ | 105,000,000 | $ | 45,000,000 | ||||||
RBS Securities Inc. |
$ | 75,000,000 | $ | 105,000,000 | $ | 45,000,000 | ||||||
Credit Suisse Securities (USA) LLC |
$ | 50,000,000 | $ | 70,000,000 | $ | 30,000,000 | ||||||
Deutsche Bank Securities Inc. |
$ | 50,000,000 | $ | 70,000,000 | $ | 30,000,000 | ||||||
Wells Fargo Securities, LLC |
$ | 50,000,000 | $ | 70,000,000 | $ | 30,000,000 | ||||||
BNP Paribas Securities Corp. |
$ | 25,000,000 | $ | 35,000,000 | $ | 15,000,000 | ||||||
Mitsubishi UFJ Securities (USA), Inc. |
$ | 25,000,000 | $ | 35,000,000 | $ | 15,000,000 | ||||||
SunTrust Robinson Humphrey, Inc. |
$ | 25,000,000 | $ | 35,000,000 | $ | 15,000,000 | ||||||
Banca IMI S.p.A. |
$ | 16,670,000 | $ | 23,338,000 | $ | 10,002,000 | ||||||
Goldman, Sachs & Co. |
$ | 16,665,000 | $ | 23,331,000 | $ | 9,999,000 | ||||||
Morgan Stanley & Co. Incorporated |
$ | 16,665,000 | $ | 23,331,000 | $ | 9,999,000 | ||||||
Total |
$ | 500,000,000 | $ | 700,000,000 | $ | 300,000,000 |
SCHEDULE II
SCHEDULE OF ISSUER FREE WRITING PROSPECTUSES
Pricing Term Sheet, dated November 1, 2010, attached hereto
SCHEDULE III
SIGNIFICANT SUBSIDIARIES
Jurisdiction of | ||||
Name of Subsidiary | Incorporation | |||
Northrop Grumman Systems Corporation (formerly Northrop Grumman Corporation) |
Delaware | |||
Northrop Grumman Shipbuilding, Inc. (formerly Newport News Shipbuilding and Dry Dock Company) |
Virginia |
EXHIBIT A
OPINIONS OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP
(i) The Company has been duly incorporated and is validly existing as a corporation in good
standing under the laws of the State of Delaware, with corporate power and authority to own or
lease its properties and conduct its business as described in the Registration Statement, the
General Disclosure Package and the Prospectus. Each of the Subsidiaries is validly existing as a
corporation in good standing under the laws of the jurisdiction of its incorporation, with
corporate power and authority to own or lease its properties and conduct its business as described
in the Registration Statement, the General Disclosure Package and the Prospectus.
(ii) The Company and each of the Subsidiaries are duly qualified to transact business in the
jurisdictions listed on Schedule 1 attached hereto.
(iii) The outstanding shares of capital stock of each of the Subsidiaries (other than Northrop
Grumman Shipbuilding, Inc.) have been duly authorized and validly issued and are fully paid and
non-assessable, and are owned of record by the Company or a Subsidiary.
(iv) The Companys authorized capital consists of (a) 800,000,000 shares of common stock, of
which to our knowledge __________ shares are issued and outstanding; and (b) 10,000,000 shares of
preferred stock, none of which to our knowledge have been issued or are outstanding.
(v) To our knowledge, except as described in the Registration Statement, the General
Disclosure Package and the Prospectus, no holder of any securities of the Company or any other
person has the right, contractual or otherwise, which has not been satisfied or effectively waived,
to cause the Company to sell or otherwise issue to such person, or to permit such person to
underwrite the sale of, any of the Notes or the right to have any Notes or other securities of the
Company included in the Registration Statement or the right, as a result of the filing of the
Registration Statement, to require registration under the Act of any securities of the Company.
(vi) The Registration Statement has become effective under the Act, and to our knowledge, no
stop order suspending the effectiveness of the Registration Statement has been issued and no
proceedings for that purpose have been instituted, are pending before, or threatened by, the
Commission.
(vii) The Registration Statement, the Prospectus and each amendment or supplement thereto at
their respective Applicable Dates complied as to form in all material respects with the
requirements of the Act, the Exchange Act or the Trust Indenture Act, as applicable, and the
applicable rules and regulations thereunder (except we will express no opinion as to the financial
statements and related notes and schedules, and financial information derived therefrom, included
therein, incorporated by reference, or omitted therefrom).
(viii) To our knowledge, there are no contracts or documents required to be filed as exhibits
to the Registration Statement or to any documents incorporated by reference therein which are not
so filed as required.
(ix) The statements under the captions Description of Senior Debt Securities and
Description of Notes in the Prospectus, insofar as such statements purport to be a summary of the
Indenture and Notes, subject to the limitations contained in such statements, fairly summarize in
all material respects the information called for with respect to such documents.
(x) The statements under the caption Certain United States Federal Income Tax Considerations
in the Prospectus, insofar as such statements purport to be a summary of matters of federal tax
law, subject to the limitations contained in such statements, fairly summarize in all material
respects the tax matters described therein.
(xi) We know of no material legal or governmental proceedings pending or threatened against
the Company or any of the Subsidiaries required to be described in the Registration Statement, the
General Disclosure Package or the Prospectus which are not so described as required.
(xii) The execution and delivery of the Underwriting Agreement and the Indenture and the
consummation of the transactions contemplated thereby (including the issuance and sale of the Notes
to the Underwriters) do not and will not conflict with or violate any of the terms or provisions of
the charter or by-laws of the Company, or conflict with or result in a breach of, or default under,
any of the terms or provisions of any indenture, mortgage, deed of trust or other agreement or
instrument to which the Company or any of the Subsidiaries is a party or by which the Company or
any of the Subsidiaries may be bound and which indenture, mortgage, deed of trust or other
agreement or instrument is listed on Schedule 2 attached hereto.
(xiii) The Underwriting Agreement has been duly and validly authorized and duly executed and
delivered by the Company.
(xiv) No approval, consent, order, authorization, designation, declaration or filing by or
with any regulatory, administrative or other governmental body under the Delaware General
Corporation Law, the laws of the States of California and New York or the federal laws of the
United States is necessary in connection with the execution and delivery of the Underwriting
Agreement and the consummation of the transactions herein contemplated (other than as may be
required by FINRA or as required by state securities and Blue Sky laws as to which we need
express no opinion), except such as have been obtained or made under the Act.
(xv) The Company is not, and will not become, as a result of the consummation of the
transactions contemplated by the Underwriting Agreement, and application of the net proceeds
therefrom as described in the Prospectus under the caption Use of Proceeds, required to register
as an investment company under the 1940 Act.
(xvi) The Company has all requisite corporate power and authority to perform each of its
obligations under the Indenture and the Notes. Each of the Original Indenture and the First
Supplemental Indenture has been duly and validly authorized, duly executed
and delivered by the Company and (assuming the due authorization, execution and delivery
thereof by the Trustee), constitutes the valid and legally binding agreement of the Company,
enforceable against the Company in accordance with its terms; the Second Supplemental Indenture has
been duly and validly authorized and, when executed and delivered by the Company (assuming the due
authorization, execution and delivery by the Trustee), will constitute a valid and legally binding
agreement of the Company, enforceable against the Company in accordance with its terms. Section
309(a) of the Trust Indenture Act provides that the Original Indenture shall be deemed to have been
qualified under the Trust Indenture Act when the Registration Statement became effective under the
Act.
(xvii) The Notes are in the form contemplated by the Indenture. The Notes have each been duly
and validly authorized by the Company and, when duly executed and delivered by the Company and paid
for by the Underwriters in accordance with the terms of the Underwriting Agreement (assuming the
due authorization, execution and delivery of the Indenture by the Trustee and due authentication
and delivery of the Notes by the Trustee in accordance with the Indenture), will constitute
Securities under the terms of the Indenture, will constitute the valid and legally binding
obligations of the Company, entitled to the benefits of the Indenture, and will be enforceable
against the Company in accordance with their terms.
(xviii) The Indenture and the Notes conform in all material respects to the descriptions
thereof contained in the General Disclosure Package and the Prospectus.
Nothing has come to our attention which caused us to believe that (i) the Registration Statement,
as of its date and as of the date hereof, pursuant to, and within the meaning of, Rule 430B(f)(2)
under the Act, contained or contains an untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the statements therein not
misleading; (ii) the General Disclosure Package, at the Applicable Time (which you have informed us
is a time prior to the time of the first sale of the Notes by any Underwriter), included an untrue
statement of a material fact or omitted to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading;
and (iii) the Prospectus, as of its date and at the date hereof, included or includes an untrue
statement of a material fact or omitted or omits to state a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not
misleading. (With respect to such statement, we may state that (A) in the course of the
preparation of the Registration Statement and the Prospectus and the preparation and/or review of
the General Disclosure Package, we participated in conferences with certain officers, employees and
representatives of the Company, with representatives of the Companys independent accountants and
with the Representatives and counsel for the Underwriters, have not independently verified the
accuracy, completeness or fairness of the statements contained in the Registration Statement, the
Prospectus and the General Disclosure Package and do not assume any responsibility for the
accuracy, completeness or fairness of the statements contained therein, except to the extent of the
preceding sentence and paragraphs (ix), (x) and (xi), and (B) we are expressing no view as to
Statements of Eligibility on Form T-1 or the financial statements and related notes and schedules
or the other financial or statistical data included or incorporated by reference in the
Registration Statement, the Prospectus or the General Disclosure Package or omitted
therefrom).
SCHEDULE 1 TO EXHIBIT A
Northrop Grumman Corporation
California
Delaware
Delaware
Northrop Grumman Systems Corporation
Alabama
|
Iowa | New Jersey | Virginia | |||
Alaska
|
Kansas | New Mexico | Washington | |||
Arizona
|
Kentucky | New York | West Virginia | |||
Arkansas
|
Louisiana | North Carolina | Wisconsin | |||
California
|
Maine | North Dakota | Wyoming | |||
Colorado
|
Maryland | Ohio | ||||
Connecticut
|
Massachusetts | Oklahoma | ||||
Delaware
|
Michigan | Oregon | ||||
District of Columbia
|
Minnesota | Pennsylvania | ||||
Florida
|
Mississippi | Rhode Island | ||||
Georgia
|
Missouri | South Carolina | ||||
Hawaii
|
Montana | South Dakota | ||||
Idaho
|
Nebraska | Tennessee | ||||
Illinois
|
Nevada | Texas | ||||
Indiana
|
New Hampshire | Utah |
Northrop Grumman Shipbuilding, Inc.
California
|
Idaho | Pennsylvania | ||||
Connecticut
|
Louisiana | Rhode Island | ||||
District of Columbia
|
Maine | South Carolina | ||||
Florida
|
Maryland | Virginia | ||||
Georgia
|
Mississippi | Washington | ||||
Hawaii |
SCHEDULE 2 TO EXHIBIT A
| Indenture dated as of October 15, 1994, between Northrop Grumman Systems Corporation and JPMorgan Chase Bank (formerly The Chase Manhattan Bank), as trustee; | |
| Form of Officers Certificate establishing the terms of Northrop Grumman Corporations (predecessor-in-interest to Northrop Grumman Systems Corporations) 7.75 percent Debentures due 2016 and 7.875 percent Debentures due 2026 | |
| Form of Northrop Grumman Systems Corporations 7.75 percent Debentures due 2016; | |
| Form of Northrop Grumman Systems Corporations 7.875 percent Debentures due 2026; | |
| Form of Officers Certificate establishing the terms of Northrop Grumman Corporations (predecessor-in-interest to Northrop Grumman Systems Corporations) 7.125 percent Notes due 2011 and 7.75 percent Debentures due 2031 | |
| Indenture dated as of April 13, 1998, between Litton Industries, Inc. (predecessor-in-interest to Northrop Grumman Systems Corporation) and The Bank of New York, as trustee, under which its 6.75 percent Senior Debentures due 2018 were issued; | |
| Supplemental Indenture with respect to Indenture dated April 13, 1998, dated as of April 3, 2001, among Litton Industries, Inc. (predecessor-in-interest to Northrop Grumman Systems Corporation), Northrop Grumman Corporation, Northrop Grumman Systems Corporation and The Bank of New York, as trustee; | |
| Supplemental Indenture with respect to Indenture dated April 13, 1998, dated as of December 20, 2002, among Litton Industries, Inc. (predecessor-in-interest to Northrop Grumman Systems Corporation), Northrop Grumman Corporation, Northrop Grumman Systems Corporation and The Bank of New York, as trustee; | |
| Senior Indenture dated as of December 15, 1991, between Litton Industries, Inc. (predecessor-in-interest to Northrop Grumman Systems Corporation) and The Bank of New York, as trustee, under which its 7.75 percent and 6.98 percent debentures due 2026 and 2036 were issued and specimens of such debentures; | |
| Supplemental Indenture with respect to Indenture dated December 15, 1991, dated as of April 3, 2001, among Litton Industries, Inc. (predecessor-in-interest to Northrop Grumman Systems Corporation), Northrop Grumman Corporation, Northrop Grumman Systems Corporation and The Bank of New York, as trustee; | |
| Supplemental Indenture with respect to Indenture dated December 15, 1991, dated as of December 20, 2002, among Litton Industries, Inc. (predecessor-in-interest to Northrop Grumman Systems Corporation), Northrop Grumman Corporation, Northrop Grumman Systems Corporation and The Bank of New York, as trustee; | |
| Indenture between TRW Inc. (predecessor-in-interest to Northrop Grumman Systems Corporation) and The Bank of New York Mellon, as successor Trustee, dated as of May 1, 1986; |
| First Supplemental Indenture between TRW Inc. (predecessor-in-interest to Northrop Grumman Systems Corporation) and The Bank of New York Mellon, as successor Trustee, dated as of August 24, 1989; | |
| Fifth Supplemental Indenture between TRW Inc. (predecessor-in-interest to Northrop Grumman Systems Corporation) and The Bank of New York Mellon, as successor Trustee, dated as of June 2, 1999; | |
| Ninth Supplemental Indenture dated as of December 31, 2009 among Northrop Grumman Space & Mission Systems Corp. (predecessor-in-interest to Northrop Grumman Systems Corporation), The Bank of New York Mellon, as successor Trustee, Northrop Grumman Corporation and Northrop Grumman Systems Corporation | |
| Indenture dated as of November 21, 2001 between Northrop Grumman Corporation and The Bank of New York Mellon (as successor-in-interest to JPMorgan Chase Bank), the trustee; | |
| First Supplemental Indenture dated as of July 30, 2009, between Northrop Grumman Corporation and The Bank of New York Mellon, as successor trustee, to Indenture dated as of November 21, 2001 | |
| Form of Northrop Grumman Corporations 3.70 percent Senior Note due 2014 | |
| Form of Northrop Grumman Corporations 5.05 percent Senior Note due 2019 | |
| Form of Amended and Restated Credit Agreement dated as of August 10, 2007, among Northrop Grumman Corporation, as Borrower; Northrop Grumman Systems Corporation and Northrop Grumman Space & Mission Systems Corp., as Guarantors; the Lenders party thereto; JPMorgan Chase Bank, N.A., as Payment Agent, an Issuing Bank, Swingline Lender and Administrative Agent; Credit Suisse, as Administrative Agent; Citicorp USA, Inc., as Syndication Agent; Deutsche Bank Securities Inc. and The Royal Bank of Scotland PLC, as Documentation Agents; and BNP Paribas as Co-Documentation Agent; | |
| Form of Guarantee dated as of April 3, 2001, by Northrop Grumman Corporation of indenture indebtedness issued by the former Litton Industries, Inc.; | |
| Form of Guarantee dated as of April 3, 2001, by Northrop Grumman Corporation of Northrop Grumman Systems Corporation indenture indebtedness; | |
| Form of Guarantee dated as of March 27, 2003, by Northrop Grumman Corporation, as Guarantor, in favor of JP Morgan Chase Bank (formerly The Chase Manhattan Bank), as trustee, of certain debt securities of Northrop Grumman Space & Mission Systems Corp. (formerly TRW Inc.); | |
| Registration Rights Agreement dated as of January 23, 2001, by and among Northrop Grumman Systems Corporation, Northrop Grumman Corporation and Unitrin, Inc. |